Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PIQRAY safely and effectively. See full prescribing information for PIQRAY. PIQRAY® (alpelisib) tablets, for oral use Initial U.S. Approval: 2019
Medication labelWhy this: Advisory · dailymed-prescription
PIQRAY is indicated in combination with fulvestrant for the treatment of adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen.
- generic_name
- alpelisib
- product_names
- alpelisib
- ndc
- 0078-0708, 0078-0708-51, 0078-0708-02, 0078-0708-90, 0078-0708-91, 0078-0715, 0078-0715-61, 0078-0715-02, 0078-0715-94, 0078-0715-91, 0078-0701, 0078-0701-51, 0078-0701-84
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en